tiprankstipranks
Carisma Therapeutics (CARM)
NASDAQ:CARM
Holding CARM?
Track your performance easily

Carisma Therapeutics (CARM) Financial Statements

1,539 Followers

Carisma Therapeutics Financial Overview

Carisma Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.556; its P/E ratio is -0.55; Carisma Therapeutics is scheduled to report earnings on April 8, 2025, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 80.20M$ 83.59M$ 90.79M$ 4.29M$ 3.83M
Gross Profit$ 80.20M$ 83.59M$ 90.79M$ 83.54M$ 3.80M
EBIT$ -12.70M$ -11.16M$ -18.74M$ -22.45M$ -22.34M
EBITDA$ -10.96M$ -7.70M$ -15.69M$ -21.73M$ -21.65M
Net Income Common Stockholders$ -12.70M$ -11.16M$ -18.98M$ -20.96M$ -21.40M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 26.88M$ 40.36M$ 56.52M$ 77.61M$ 94.14M
Total Assets$ 42.06M$ 59.34M$ 73.80M$ 89.55M$ 106.78M
Total Debt$ 3.32M$ 3.76M$ 7.49M$ 3.12M$ 2.75M
Net Debt$ -23.56M$ -36.60M$ -49.02M$ -74.48M$ -91.39M
Total Liabilities$ 53.18M$ 58.98M$ 62.90M$ 63.02M$ 60.49M
Stockholders Equity$ -11.08M$ 402.00K$ 10.88M$ 26.53M$ 46.30M
Cash Flow-
Free Cash Flow$ -13.02M$ -16.23M$ -22.44M$ -16.66M$ -21.19M
Operating Cash Flow$ -13.02M$ -16.12M$ -22.43M$ -16.10M$ -21.00M
Investing Cash Flow-$ -106.00K$ -17.00K$ 10.44M$ 29.81M
Financing Cash Flow$ -461.00K$ 73.00K$ 1.35M$ 101.00K$ -2.03M
Currency in USD

Carisma Therapeutics Earnings and Revenue History

Carisma Therapeutics Debt to Assets

Carisma Therapeutics Cash Flow

Carisma Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis